10:39 AM EDT, 10/02/2024 (MT Newswires) -- Charles River Laboratories International ( CRL ) said Wednesday that it agreed to a deal with H. Lundbeck to use Logica artificial intelligence-powered drug discovery platform for brain disease research.

Financial terms of the agreement were not disclosed.

Charles River shares were down 1.4% in recent trading.

Price: 191.33, Change: -2.75, Percent Change: -1.42